Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: J Pain. 2021 Oct 20;23(3):450–458. doi: 10.1016/j.jpain.2021.09.007

Table 2.

Pain Medication Use by Total Joint Arthroplasty and Chronic Pain Grade

Self-Reported Non-Opioid Medication Use
All Arthroplasty
(n = 2638)		 Total Knee
(n = 1265)		 Total Hip
(n = 1146)		 Total Shoulder
(n = 227)
Chronic Pain Absent 38.7%
(455/1175)		 41.8%
(216/517)		 35.7%
(202/566)		 40.2%
(37/92)
Mild Chronic Pain 48.0%
(233/485)		 51.4%
(132/257)		 41.2%
(80/194)		 61.8%
(21/34)
Bothersome Chronic Pain 53.7%
(372/693)		 57.8%
(200/346)		 50.4%
(137/272)		 46.7%
(35/75)
High Impact Chronic Pain 58.9%
(168/285)		 62.1%
(90/145)		 53.5%
(61/114)		 65.4%
(17/26)
p-value < 0.001 < 0.001 < 0.001 0.046
Self-Reported Opioid Medication Use
All Arthroplasty
(n = 2638)		 Total Knee
(n = 1265)		 Total Hip
(n = 1146)		 Total Shoulder
(n = 227)
Chronic Pain Absent 1.4%
(17/1175)		 1.5%
(8/517)		 1.2%
(7/566)		 2.2%
(2/92)
Mild Chronic Pain 1.2%
(6/485)		 1.2%
(3/257)		 1.5%
(3/194)		 0.0%
(0/34)
Bothersome Chronic Pain 6.3%
(44/693)		 7.8%
(27/346)		 5.1%
(14/272)		 4.0%
(3/75)
High Impact Chronic Pain 15.4%
(44/285)		 13.1%
(19/145)		 14.9%
(17/114)		 30.8%
(8/26)
p-value < 0.001 < 0.001 < 0.001 < 0.001

• P-values for frequency differences in chronic pain grade within each arthroplasty location (via chi-square)